STING agonist-20
STING agonist-20 (compound 95) is a potent STING agonist used in the synthesis of XMT-2056. STING agonist-20 can be used as a vaccine adjuvant in the study of cancer and other inflammatory, immune diseases[1].
Product Specifications
CAS Number
2591300-72-8
UNSPSC
12352005
Target
STING
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sting-agonist-20.html
Concentration
10mM
Purity
99.79
Solubility
DMSO : 80 mg/mL (ultrasonic)
Smiles
O=C(C1=C(N=C(O1)C)CC)NC2=NC3=CC(C(N)=O)=CN=C3N2C/C=C/CN4C5=C(OCCCO)C=C(C(N)=O)C=C5N=C4NC(C6=C(N=C(O6)C)CC)=O
Molecular Formula
C36H39N11O8
Molecular Weight
753.76
References & Citations
[1]R. DUVALL J, et al., Sting agonist compounds and methods of use. US20210032269
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Colloidal Gold Conjugated Monoclonal Antibody to Herpes Simplex II, 10nm
